(S (NP (NP (JJ Adverse) (NN drug) (NNS events)) (-LRB- -LRB-) (NP (NN ADE)) (-RRB- -RRB-)) (VP (VBP are) (ADJP (JJ prevalent) (CC and) (JJ costly))) (. .))
(S (NP (JJ Clinical) (NNS trials)) (VP (VBP are) (VP (VBN constrained) (PP (IN in) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB identify) (NP (JJ potential) (NNS ADEs))))))) (, ,) (S (VP (VBG motivating) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ spontaneous) (NN reporting) (NNS systems)))) (PP (IN for) (NP (JJ post-market) (NN surveillance))))))) (. .))
(S (NP (JJ Statistical) (NNS methods)) (VP (VP (VBP provide) (NP (DT a) (JJ convenient) (NN way)) (S (VP (TO to) (VP (VB detect) (NP (NNS signals)) (PP (IN from) (NP (DT these) (NNS reports))))))) (CC but) (VP (VBP have) (NP (NP (NNS limitations)) (PP (IN in) (S (VP (VBG leveraging) (NP (NP (NNS relationships)) (PP (IN between) (NP (NNS drugs) (CC and) (NNS ADEs)))) (PP (VBN given) (NP (PRP$ their) (ADJP (NP (JJ discrete) (NN count)) (HYPH -) (VBN based)) (NN nature))))))))) (. .))
(S (NP (NP (DT A) (ADJP (RB previously) (VBN proposed)) (NN method)) (, ,) (NP (NN aer2vec)) (, ,)) (VP (VBZ generates) (NP (NP (NP (VBN distributed) (NN vector) (NNS representations)) (PP (IN of) (NP (NNP ADE) (NN report) (NNS entities)))) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP capture) (NP (NP (NNS patterns)) (PP (IN of) (NP (NN similarity))))) (CC but) (VP (MD can) (RB not) (VP (VB utilize) (NP (JJ lexical) (NN knowledge))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBP address) (NP (DT this) (NN limitation)) (PP (IN by) (NP (NN retrofitting) (NN aer2vec) (NN drug) (NNS embeddings))) (PP (IN to) (NP (NP (NN knowledge)) (PP (IN from) (NP (NNP RxNorm)))))) (CC and) (VP (VBG developing) (NP (DT a) (JJ novel) (NN retrofitting) (NN variant)) (S (VP (VBG using) (NP (NN vector) (NN rescaling)) (S (VP (TO to) (VP (VB preserve) (NP (NN magnitude))))))))) (. .))
(S (SBAR (WHADVP (WRB When)) (S (VP (VBN evaluated) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (DT a) (NN pharmacovigilance) (NN signal) (NN detection) (NN task)))))))) (, ,) (NP (NP (NN aer2vec)) (PP (IN with) (NP (NN retrofitting)))) (ADVP (RB consistently)) (VP (VBZ outperforms) (NP (NN disproportionality) (NNS metrics)) (SBAR (WHADVP (WRB when)) (S (VP (VBN trained) (PP (IN on) (NP (ADVP (RB minimally)) (JJ preprocessed) (NNS data))))))) (. .))
(S (S (VP (VBG Retrofitting) (PP (IN with) (NP (NP (NN rescaling) (NNS results)) (PP (IN in) (NP (NP (JJ further) (NNS improvements)) (PP (IN in) (NP (DT the) (ADJP (JJR larger) (CC and) (JJR more)) (ADJP (JJ challenging) (PP (IN of) (NP (CD two) (NN pharmacovigilance)))) (NN reference) (NNS sets))))))))) (VP (VBN used) (PP (IN for) (NP (NN evaluation)))) (. .))
